SCHEMBL7506646

SCHEMBL7506646

CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)NCC(O)c2ccc(O)cc2)[C@@H](O)[C@H]1O

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ P2RY12 Q9H244 18/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7510795 1.00 P2RY12 (0.68) P2RY12
SCHEMBL7504496 0.92 P2RY12 (0.65) P2RY12
SCHEMBL7504505 0.92 P2RY12 (0.65) P2RY12
SCHEMBL7508816 0.88 P2RY12 (0.72) P2RY12
SCHEMBL7508817 0.88 P2RY12 (0.72) P2RY12
SCHEMBL7511128 0.88 P2RY12 (0.71) P2RY12
SCHEMBL7511124 0.88 P2RY12 (0.71) P2RY12
SCHEMBL7511007 0.87 P2RY12 (0.74) P2RY12
SCHEMBL7511011 0.87 P2RY12 (0.74) P2RY12
SCHEMBL6995015 0.86 P2RY12 (0.84) P2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946561-B1 TRIAZOLO(4,5-D)PYRIMIDINYL DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 2002-02-13 — — EP claimed
US-6297232-B1 TREATMENT OF PLATELET AGGREGATION DISORDERS. ASTRAZENECA AB (SE) 2001-10-02 — — US claimed
EP-0946561-B1 TRIAZOLO(4,5-D)PYRIMIDINYL DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 2002-02-13 — — EP disclosed
US-6297232-B1 TREATMENT OF PLATELET AGGREGATION DISORDERS. ASTRAZENECA AB (SE) 2001-10-02 — — US disclosed
Send feedback